不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020.
Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本文介绍了 PGINKTL 的临床特征和不良结局,PGINKTL 是一种罕见且致命的淋巴瘤类型。
原发性胃肠道自然杀伤(NK)/T细胞淋巴瘤(PGINKTL)是一种罕见的T/NK细胞淋巴瘤亚型,其临床特征和生存结局仍知之甚少。
为总结PGINKTL的临床特征和生存结局,研究人员回顾了本院1999年5月至2020年12月确诊病例,收集临床资料、治疗方案和生存信息。使用Kaplan-Meier法和多变量Cox比例风险回归进行生存分析,并构建可视化的预后列线图;通过一致性指数(C指数)和校准图检验列线图的区分能力及校准度。
队列共纳入81例患者,中位年龄36岁(范围7–80岁),男女比例为1.7:1。最常见的首发症状为腹痛(71.6%),最常见病灶部位为结肠(59.3%)。中位随访37.7个月期间,81例患者的中位总生存期(OS)仅4.0个月(95%置信区间[CI]:3.1–4.9个月),2年OS率为30.7%(95% CI:20.3%–40.1%)。多变量分析显示,ECOG体能状态评分≥2、血清乳酸脱氢酶(LDH)水平高于正常值上限以及肠穿孔均与较差OS相关。研究人员据此建立PGINKTL生存预测列线图,其准确性较好,C指数为0.726。
本文介绍了PGINKTL这一罕见且致死性淋巴瘤的临床特征和不良结局。所提出的列线图可为患者提供个体化生存估计。未来需开展研究,探索改善PGINKTL患者生存的更佳治疗策略。
Primary gastrointestinal natural killer (NK)/T-cell lymphoma (PGINKTL) is a rare T-/NK-cell lymphoma subtype, and the clinical features and survival outcomes remain largely unknown.
To summarize the clinical features and survival outcomes of PGINKTL, PGINKTL cases diagnosed at our hospital from May 1999 to December 2020 were reviewed; and the clinical data, information on treatment strategies, and survival were collected. Survival analysis was performed using the Kaplan-Meier method and multivariable Cox proportional hazards regression. We constructed a nomogram to visualize the survival prediction of PGINKTL. The discriminative ability and calibration of the nomogram for prediction were tested using the concordance index (C-index) and calibration plots.
The cohort included 81 cases, the median age was 36 years (range, 7-80 years), and the male-to-female ratio was 1.7:1. The most common clinical symptom at the time of diagnosis was abdominal pain (71.6%). The most common lesion site was the colon (59.3%). During a median follow-up period of 37.7 months, the median overall survival (OS) time of 81 patients was 4.0 months (95% confidence interval [CI], 3.1-4.9 months), and the 2-year OS rate was 30.7% (95% CI, 20.3%-40.1%). The multivariate analyses indicated that patients with an Eastern Cooperative Oncology Group (ECOG) performance status (PS) score 2, serum lactic dehydrogenase (LDH) level the upper limit normal (ULN), and perforation had worse OS. We used these data to establish a nomogram to predict survival for PGINKTL. The nomogram displayed good accuracy, with a C-index of 0.726.
The clinical features and poor outcomes of PGINKTL, which is a rare and fatal lymphoma type, are presented. The proposed nomogram provides an individualized estimate of survival for these patients. In the future, the study focused on exploring a better treatment strategy to improve survival is required in PGINKTL.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。